Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert E Denroche

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2020
Delving into Early-onset Pancreatic Ductal Adenocarcinoma: How Does Age Fit In?Erica S Tsang, James T Topham, Joanna M Karasinska, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2020
A Four-Chemokine Signature Is Associated with a T-cell-Inflamed Phenotype in Primary and Metastatic Pancreatic CancerJoan M Romero, Barbara Grünwald, Gun-Ho Jang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2019
<i>NRG1</i> Gene Fusions Are Recurrent, Clinically Actionable Gene Rearrangements in <i>KRAS</i> Wild-Type Pancreatic Ductal AdenocarcinomaMartin R Jones, Laura M Williamson, James T Topham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 31, 2017
Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS TrialKyaw L Aung, Sandra E Fischer, Robert E Denroche, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2020
A Preclinical Trial and Molecularly Annotated Patient Cohort Identify Predictive Biomarkers in Homologous Recombination-deficient Pancreatic CancerYifan Wang, Jin Yong Patrick Park, Alain Pacis, et al.
Nature Communications|October 8, 2022
Integrative analysis of KRAS wildtype metastatic pancreatic ductal adenocarcinoma reveals mutation and expression-based similarities to cholangiocarcinomaJames T Topham, Erica S Tsang, Joanna M Karasinska, et al.
JAMA Oncology|October 22, 2016
Association of Distinct Mutational Signatures With Correlates of Increased Immune Activity in Pancreatic Ductal AdenocarcinomaAshton A Connor, Robert E Denroche, Gun Ho Jang, et al.
Nature Genetics|February 14, 2020
Author Correction: Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolutionMichelle Chan-Seng-Yue, Jaeseung C Kim, Gavin W Wilson, et al.
Cancer Cell|January 29, 2019
Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in MetastasesAshton A Connor, Robert E Denroche, Gun Ho Jang, et al.
Carcinogenesis|November 23, 2015
Fine mapping of chromosome 5p15.33 based on a targeted deep sequencing and high density genotyping identifies novel lung cancer susceptibility lociLinda Kachuri, Christopher I Amos, James D McKay, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2020
Delving into Early-onset Pancreatic Ductal Adenocarcinoma: How Does Age Fit In?Erica S Tsang, James T Topham, Joanna M Karasinska, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2020
A Four-Chemokine Signature Is Associated with a T-cell-Inflamed Phenotype in Primary and Metastatic Pancreatic CancerJoan M Romero, Barbara Grünwald, Gun-Ho Jang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2019
<i>NRG1</i> Gene Fusions Are Recurrent, Clinically Actionable Gene Rearrangements in <i>KRAS</i> Wild-Type Pancreatic Ductal AdenocarcinomaMartin R Jones, Laura M Williamson, James T Topham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 31, 2017
Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS TrialKyaw L Aung, Sandra E Fischer, Robert E Denroche, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2020
A Preclinical Trial and Molecularly Annotated Patient Cohort Identify Predictive Biomarkers in Homologous Recombination-deficient Pancreatic CancerYifan Wang, Jin Yong Patrick Park, Alain Pacis, et al.
Nature Communications|October 8, 2022
Integrative analysis of KRAS wildtype metastatic pancreatic ductal adenocarcinoma reveals mutation and expression-based similarities to cholangiocarcinomaJames T Topham, Erica S Tsang, Joanna M Karasinska, et al.
JAMA Oncology|October 22, 2016
Association of Distinct Mutational Signatures With Correlates of Increased Immune Activity in Pancreatic Ductal AdenocarcinomaAshton A Connor, Robert E Denroche, Gun Ho Jang, et al.
Nature Genetics|February 14, 2020
Author Correction: Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolutionMichelle Chan-Seng-Yue, Jaeseung C Kim, Gavin W Wilson, et al.
Cancer Cell|January 29, 2019
Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in MetastasesAshton A Connor, Robert E Denroche, Gun Ho Jang, et al.
Carcinogenesis|November 23, 2015
Fine mapping of chromosome 5p15.33 based on a targeted deep sequencing and high density genotyping identifies novel lung cancer susceptibility lociLinda Kachuri, Christopher I Amos, James D McKay, et al.
Pageof 4